Biostar Pharmaceuticals, Inc. Expects 2013 Yearly Revenue Growth above 20% with Break Even Operating Results as Compared With Last Year’s USD$21.8 Million Loss from Operations

[PR Newswire] – XIANYANG, China, Feb. 20, 2014 /PRNewswire/ — Biostar Pharmaceuticals, Inc. (BSPM) (Biostar or the Company), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and co more

View todays social media effects on BSPM

View the latest stocks trending across Twitter. Click to view dashboard

See who Biostar is hiring next, click here to view